Convatec to manufacture new infusion set for Tandem Diabetes CareDiabetes Care

18 Jul 2023
www.outsourcing-pharma.com
Tandem Mobi is the latest insulin pump from Tandem Diabetes CareDiabetes Care. The new insulin pump system aims to provide people living with diabetes with new options in wearability, the flexibility to disconnect, and full smartphone control.
It has a 200-unit capacity, and is controllable from a mobile app. The device can fit in a coin pocket, be clipped to clothing, or worn on-body with an adhesive sleeve.
Specifically for Tandem Mobi, Convatec has developed the AutoSoft XC with a new 12 cm tubing. This set is now the shortest tubing provided by Convatec, enabling users to wear the pump as an on-body system, providing 'discretion but also flexibility'.
Convatec will manufacture the infusion sets for the insulin pumps in the Tandem product portfolio, including the currently available t:slim X2 insulin pump.
Tandem infusion set options include AutoSoft XC, AutoSoft 90, AutoSoft 30, VariSoft and TruSteel.
These products allow users to temporarily disconnect from their pump for convenience and provide the flexibility of more than 30 mix-and-match infusion site and tubing length combinations, depending on their lifestyles and wear preference.
Convatec will manufacture these sets at its production sites in Mexico.
Kjersti Grimsrud, president and chief operating officer at Convatec, said: “We are pleased to continue working with Tandem with whom we have had a longstanding partnership. This partnership further demonstrates Convatec’s leadership in infusion technology and the trust from our partners to collaborate on innovative technology to improve the quality of life of people with diabetes.”
googletag.cmd.push(function () {
googletag.display('text-ad1');
});
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.